Novo’s Wegovy Beats Lilly’s Zepbound for Heart Health, Study Finds. What It Means for Stocks. Barron’s Novo Nordisk’s Wegovy cuts heart risk by 57% versus rival Lilly weight-loss drug in study Reuters Wegovy trial result gives boost to Novo Nordisk amid U.S. market woes CNBC Weight loss drugs can halve heart patients’ risk of early death, study finds The Guardian Novo Nordisk’s Wegovy® cuts …
Read More »Tag Archives: Novos
Stock Markets Beware Summer Scares. What Microsoft Must Learn From Novo’s $75 Billion Crash. – Barron's
Stock Markets Beware Summer Scares. What Microsoft Must Learn From Novo’s $75 Billion Crash. Barron’s Novo Nordisk stock crashes after company cuts sales, profit outlook on weight-loss drug competition Yahoo Finance Drugmaker Novo Nordisk slashes Wegovy sales forecasts, blaming compounding NPR Novo Nordisk gets a downgrade from Bank of America as Wegovy growth outlook weakens CNBC Can Novo Nordisk’s New CEO Stop Rivals From …
Read More »